SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-069167
Filing Date
2012-10-15
Accepted
2012-10-15 17:05:12
Documents
11
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a12-20182_110q.htm 10-Q 342884
2 EX-31.1 a12-20182_1ex31d1.htm EX-31.1 13310
3 EX-31.2 a12-20182_1ex31d2.htm EX-31.2 12877
4 EX-32.1 a12-20182_1ex32d1.htm EX-32.1 7190
5 EX-32.2 a12-20182_1ex32d2.htm EX-32.2 6791
  Complete submission text file 0001104659-12-069167.txt   1805780

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20120831.xml EX-101.INS 163907
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20120831.xsd EX-101.SCH 17644
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20120831_cal.xml EX-101.CAL 20888
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20120831_def.xml EX-101.DEF 69055
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20120831_lab.xml EX-101.LAB 239922
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20120831_pre.xml EX-101.PRE 117578
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 121144355
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1